NCT06333951 2026-02-19
AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
Amgen
Phase 1 Recruiting
Clinical Trials
10 trialsNCT05815173 2025-12-30
Ladarixin With Sotorasib in Advanced NSCLC
NYU Langone Health
Phase 1 Recruiting
NCT04185883 2025-10-22
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Amgen
Phase 1 Active not recruiting
NCT04380753 2025-07-23
AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).
Amgen
Phase 1 Active not recruiting
NCT06249282 2025-06-17
Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT05374538 2025-05-01
VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer
Vitrac Therapeutics, LLC
Phase 1 Terminated
NCT05036291 2025-03-05
A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors
Ningbo Newbay Technology Development Co., Ltd
Phase 1 Recruiting
NCT06127940 2023-11-13
K-SAB
Karolinska University Hospital
Phase 1 Unknown
NCT05045638 2023-08-14
Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants
Amgen
Phase 1 Completed
NCT04959981 2023-07-25
HERKULES-2
Erasca, Inc.
Phase 1 Completed